Menu
Gilbert joins ERS Congress in Vienna

Gilbert joins ERS Congress in Vienna

The Gilbert team looks forward to attending the European Respiratory Society (ERS) in Vienna from Sept 7th-11th.

Our special interest is to catch up on the latest research in inhaled drug delivery therapies.

We look forward to connect with pharma and biotech decision makers to redefine treatment for lung patients together.

So if you are also visiting, let’s meet up in Vienna!

To plan a meeting, please contact us at info@Gilbert.eu or reach out directly to our team members Maurits Huigen or Scott Fleming.

Gilbert is developing the next generation of soft mist inhalers based on a proprietary electrospray (Electro Hydrodynamic Atomization or EHDA) technology to redefine treatment for lung patients. Gilbert’s breath actuated smart precision inhaler creates a monodispersed soft mist aerosol, with a customizable droplet size enabling more precise targeting of drugs to desired regions of the lungs, which has the potential to improve the efficacy and safety of treatments. Electrospray enables gentle, efficient delivery of both small and large molecule therapies in both solution and suspension formulations.

Visit us at Gilbert | Redefining treatment for lung patients, follow us on Linkedin or contact us at info@gilbert.eu to learn if electrospray is suitable for your application.

Other posts

Interview with Mehmet Uzumcu

Mehmet Uzumcu talks about electrospray and its application in the […]
Read more

Interview with Scott Fleming

Gilbert's own Scott Fleming talks about Gilbert's Smart Precision Inhaler […]
Read more

Let’s stay in touch!

Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.

Follow us on LinkedIn